In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 19-185V
UNPUBLISHED
CHRISTOPHER AGARD, Chief Special Master Corcoran
Petitioner, Filed: April 7, 2021
v.
Special Processing Unit (SPU); Joint
SECRETARY OF HEALTH AND Stipulation on Damages; Tetanus
HUMAN SERVICES, Diphtheria acellular Pertussis (Tdap)
Vaccine; Cellulitis
Respondent.
Jeffrey S. Pop, Jeffrey S. Pop & Associates, Beverly Hills, CA, for petitioner.
Mallori Browne Openchowski, U.S. Department of Justice, Washington, DC, for
respondent.
DECISION ON JOINT STIPULATION1
On January 31, 2019, Christopher Agard filed a petition for compensation under
the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the
“Vaccine Act”). Petitioner alleges that he suffered cellulitis and other complications as a
result of a Tetanus-Diphtheria-acellular-Pertussis (“Tdap”) vaccine administered on
February 6, 2018. Petition at 1; Stipulation, filed on April 6, 2021, at ¶¶ 1-2, 4. Petitioner
further alleges that the vaccine was administered within the United States; that he
suffered the residual effects of his injury for more than six months; and that there has
been no prior award or settlement of a civil action for damages on his behalf as a result
of his condition. Petition at 1-2, 10; Stipulation at ¶¶ 3-5. “Respondent denies that the
Tdap vaccine caused petitioner’s alleged cellulitis or any other injury and further denies
that his current disabilities are a sequela of a vaccine-related injury.” Stipulation at ¶ 6.
1 Because this unpublished decision contains a reasoned explanation for the action in this case, I am
required to post it on the United States Court of Federal Claims' website in accordance with the E-
Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic
Government Services). This means the decision will be available to anyone with access to the
internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact
medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy.
If, upon review, I agree that the identified material fits within this definition, I will redact such material from
public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa
(2012).
Nevertheless, on April 6, 2021, the parties filed the attached joint stipulation,
stating that a decision should be entered awarding compensation. I find the stipulation
reasonable and adopt it as my decision awarding damages, on the terms set forth therein.
Pursuant to the terms stated in the attached Stipulation, I award the following
compensation:
A lump sum of $95,000.00 in the form of a check payable to Petitioner.
Stipulation at ¶ 8. This amount represents compensation for all items of damages
that would be available under Section 15(a). Id.
I approve the requested amount for Petitioner’s compensation. In the absence of
a motion for review filed pursuant to RCFC Appendix B, the clerk of the court is directed
to enter judgment in accordance with this decision.3
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.
2
IN THE UNITED STATES COURT OF FEDERAL CLAIMS
OFFICE OF SPECIAL MASTERS
CHRISTOPHER AGARD,
Petitioner,
v. No. 19-185V
Chief Special Master Corcoran
SECRETARY OF HEALTH AND SPU
HUMAN SERVICES,
Respondent.
STIPULATION
The parties hereby stipulate to the following matters:
I. Petitioner, Christopher Agard, filed a petition for vaccine compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. § 300aa-I0 to 34 (the "Vaccine
Program"). The petition seeks compensation for injuries allegedly related to petitioner's receipt
of the Tetanus-Diphtheria-acellular-pertussis ("Tdap") vaccine, which vaccine is contained in the
Vaccine Injury Table (the "Table"), 42 C.F.R. § I 00.3 (a).
2. Petitioner received a Tdap vaccine on or about February 6, 2018.
3. The vaccine was administered within the United States.
4. Petitioner alleges that he suffered cellulitis and significant complications as a
consequence of the Tdap immunization he received on or about February 6, 2018, and further
alleges that he suffered the residual effects of this injury for more than six months.
5. Petitioner represents that there has been no prior award or settlement of a civil action
for damages on his behalf as a result of his condition.
Page I of 5
6. Respondent denies that the Tdap vaccine caused petitioner's alleged cellulitis or any
other injury and further denies that his current disabilities are a sequela of a vaccine-related injury.
7. Maintaining their above-stated positions, the parties nevertheless now agree that the
issues between them shall be settled and that a decision should be entered awarding the
compensation described in paragraph 8 of this Stipulation.
8. As soon as practicable after an entry of judgment reflecting a decision consistent with
the terms of this Stipulation, and after petitioner has filed an election to receive compensation
pursuant to 42 U.S.C. § 300aa-21(a)(l), the Secretary of Health and Human Services will issue the
following vaccine compensation payment:
A lump sum of $95,000.00, in the form of a check payable to petitioner,
representing compensation for all damages that would be available under 42 U.S.C.
§ 300aa-15(a).
9. As soon as practicable after the entry of judgment on entitlement in this case, and after
petitioner has filed both a proper and timely election to receive compensation pursuant to 42 U.S.C.
§ 300aa-2l(a)(l), and an application, the parties will submit to further proceedings before the
special master to award reasonable attorneys' fees and costs incurred in proceeding upon this
petition.
10. Petitioner and his attorney represent that they have identified to respondent all known
sources of payment for items or services for which the Program is not primarily liable under 42
U .S.C. § 300aa-15(g), including State compensation programs, insurance policies, Federal or State
health benefits programs (other than Title XIX of the Social Security Act (42 U .S.C. § 1396 et
seq.)), or entities that provide health services on a prepaid basis.
Page 2 of 5
I I. Payment made pursuant to paragraph 8 of this Stipulation and any amounts awarded
pursuant to paragraph 9 will be made in accordance with 42 U .S.C. § 300aa-I 5(i), subject to the
availability of sufficient statutory funds.
I 2. The parties and their attorneys further agree and stipulate that, except for any award
for attorney's fees and litigation costs, the money provided pursuant to this Stipulation will be used
solely for the benefit of petitioner as contemplated by a strict construction of 42 U .S.C. § 300aa-
I 5(a) and (d), and subject to the conditions of 42 U.S.C. § 300aa-15(g) and (h).
I 3. In return for the payments described in paragraphs 8 and 9, petitioner, in his individual
capacity, and on behalf of his heirs, executors, administrators, successors, and assigns, does forever
irrevocably and unconditionally release, acquit and discharge the United States and the Secretary
of Health and Human Services from any and all actions or causes of action (including agreements,
judgments, claims, damages, loss of services, expenses and all demands of whatever kind or
nature) that have been brought, could have been brought, or could be timely brought in the United
States Court of Federal Claims, under the National Vaccine Injury Compensation Program, 42
U.S.C. § 300aa-I 0 et seq., on account of, or in any way growing out of, any and all known or
unknown, suspected or unsuspected personal injuries to or death of petitioner resulting from, or
alleged to have resulted from, the Tdap vaccination administered on or about February 6, 20 I 8, as
alleged by petitioner in a petition for vaccine compensation filed on or about January 3 I, 20 I 9 in
the United States Court of Federal Claims as petition No. 19-185V.
14. If petitioner should die prior to entry of judgment, this agreement shall be voidable
upon proper notice to the Court on behalf of either or both of the parties.
15. If the special master fails to issue a decision in complete conformity with the terms of
this Stipulation or if the United States Court of Federal Claims fails to enter judgment in
Page 3 of 5
conformity with a decision that is in complete conformity with the terms of this Stipulation, then
the parties' settlement and this Stipulation shall be voidable at the sole discretion of either party.
16. This Stipulation expresses a full and complete negotiated settlement of liability and
damages claimed under the National Childhood Vaccine Injury Act of 1986, as amended, except
as otherwise noted in paragraph 9 above. There is absolutely no agreement on the part of the
parties hereto to make any payment or do any act or thing other than is herein expressly stated and
clearly agreed to. The parties further agree and understand that the award described in this
Stipulation may reflect a compromise of the parties' respective positions as to liability and/or
amount of damages, and further, that a change in the nature of the injury or condition or in the
items of compensation sought, is not grounds to modify or revise this agreement.
17. This Stipulation shall not be construed as an admission by the United States or the
Secretary of Health and Human Services that the Tdap vaccine caused petitioner's alleged cellulitis
or any other injury or any of his current disabilities.
18. All rights and obligations of petitioner hereunder shall apply equally to petitioner's
heirs, executors, administrators, successors, and/or assigns.
END OF STIPULATION
Page 4 of 5
ATTORNEYOFRECORDFOR AtJTHORlZED REPRESENTATIVE
PETITIONER: OF THE ATTORNEY GENERAL:
~
JEFFREYS. POP & ASSOCIATES
.MJ ~Qed/.4,/v--....
HEATHER L. PEARLMAN
Acting Deputy Director
9150 Wilshire Blvd Torts Branch
Suite 241 Civil Division
Beverly Hills, CA 90212 U. S. Department of Justice
(310) 273~5462 P.O.Box 146
Benjamm Franklin Station
Washington. D.C. 20044-0146
AUTBORJZED REPRESENTATIVE OF ATfORNEYOFRECOlWFOR
THE SECRETARY OF HEALTH AND RESPONDENT:
RUMAN SERVICES:
H~/~, ~~~~
~ ~~~ L ~ - e _ ~
TAMARA OVERBY MALLORI B. OPENCHOWSKI
Acting Director, Division of Trial Attorney
lnjury Compensation Programs (DICP) Torts B1uoh, Civil Division
Healthcare Systems Bureau U.S. Department of Justice
Health Resources aud Services Administration P.O. Box 146
U.S. Department of Health Benjamin F{&D}din Statton
and Human Services Washington,. D.C. 20044-0146
5600 Fisbm Lane 08N 146B Tel: (202) 305-0660
Rockville, MD 20857 mallori.b.openchowski@usdoj.gov
Dated: ~ /-z3 lzoz I
Page S of5